Transforming Neurological Therapies with SiNON's Carbon Nanotechnology
We are committed to advancing therapies for severe neurological conditions. Our Carbon Nanoparticle (CNP) technology enables targeted drug delivery across the Blood-Brain Barrier (BBB), with high specificity and controlled, sustained release. This approach maximizes drug concentration in the brain, offering key advantages.
Reduced Dosage: Smaller drug quantities reduce toxicity and side effects, enhancing patient safety.
Improved Outcomes: Targeted, sustained release boosts therapeutic effectiveness.
Cost-Efficiency: Controlled delivery lowers treatment costs, benefiting both healthcare providers and patients.
Built on scientific rigor, SiNON’s CNP platform represents a transformative advancement in neurological care. Discover how partnering with SiNON can lead to impactful progress in neurological treatments.
Expertise and Agility for Complex Challenges
SiNON Nano Sciences brings together deep expertise in nano chemistry, radiation oncology, medicine, neuroscience, biochemistry, microbiology, and business, making our team uniquely equipped to tackle complex scientific and technical challenges. Our agile structure ensures we adapt swiftly to evolving demands, and our specialized knowledge drives innovative solutions that consistently meet and often exceed expectations.
Agile structure for swift adaptation to evolving demands.
Specialized expertise to deliver innovative and exceptional solutions.
Breakthrough Solutions for Crossing the Blood-Brain Barrier
SiNON Nano Sciences has pioneered a non-invasive method to cross the Blood-Brain Barrier (BBB), enabling effective drug delivery directly to the brain. This versatile technology is applicable to a wide range of therapies, including existing drugs that could gain from improved delivery or expanded applications in neurological treatment. Key advantages include:
Broad Applicability: Adaptable to both new and existing drugs, opening doors for enhanced delivery and expanded therapeutic possibilities.
Safe & Targeted Delivery: Offers a non-invasive, efficient pathway for brain-targeted therapies, unlocking new potential in neurological care.
See how SiNON’s solutions can enhance your therapies for impactful results in neurological treatment.
Partnering with SiNON
We collaborate closely with our partners to develop tailored nanoparticle formulations that enhance the delivery and efficacy of their therapies. From initial assessments and feasibility studies to advanced development and scalable implementation, we optimize each solution for therapeutic impact, addressing precise therapeutic needs. Our Carbon Nanoparticle (CNP) platform provides an effective delivery mechanism that enhances drug bioavailability, reduces toxicity, and improves target specificity. This enables the creation of advanced formulations for biologics and therapeutic agents, including drugs that previously faced challenges, such as high toxicity or difficulty crossing the blood-brain barrier (BBB). By integrating our CNPs, we can potentially reposition drugs that struggled in clinical trials, offering new pathways to market.
Optimized CNP delivery enhances bioavailability, reduces toxicity, and improves target specificity.
Repositions previously challenged drugs, overcoming barriers like BBB limitations and clinical toxicity.
Our Solution
The Carbon Nano Particle is a versatile nanoparticle made of carbon, capable of transporting drugs or markers into the brain.
Drug Encapsulation for Targeted Delivery
Platform drug delivery via Trojan Horse